limonene has been researched along with Prostatic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Demarais, R; Jayaprakasha, GK; Murthy, KN; Patil, BS | 1 |
| Chen, J; Dong, J; Jing, Y; Lu, M | 1 |
| Miller, AC; Samid, D | 1 |
3 other study(ies) available for limonene and Prostatic Neoplasms
| Article | Year |
|---|---|
Inhibition of prostate cancer (LNCaP) cell proliferation by volatile components from Nagami kumquats.
Topics: Acyclic Monoterpenes; Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Cell Count; Cell Line, Tumor; Cell Proliferation; Cyclohexenes; Cyclooxygenase 2; Distillation; Drug Screening Assays, Antitumor; Gas Chromatography-Mass Spectrometry; Humans; Limonene; Magnetic Resonance Spectroscopy; Male; Monoterpenes; NF-kappa B; Oils, Volatile; Plant Oils; Propionates; Prostatic Neoplasms; Rutaceae; Sesquiterpenes, Germacrane; Terpenes; Time Factors; Volatile Organic Compounds | 2012 |
The synthesis of L-carvone and limonene derivatives with increased antiproliferative effect and activation of ERK pathway in prostate cancer cells.
Topics: Actins; Antineoplastic Agents, Phytogenic; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Cyclohexane Monoterpenes; Cyclohexenes; Extracellular Signal-Regulated MAP Kinases; Farnesyltranstransferase; Humans; Indicators and Reagents; Limonene; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Mitogen-Activated Protein Kinases; Monoterpenes; Prostatic Neoplasms; Signal Transduction; Structure-Activity Relationship; Terpenes; Tetrazolium Salts; Thiazoles | 2006 |
Tumor radiosensitization based on the use of inhibitors of the mevalonate pathway of cholesterol synthesis.
Topics: Adenocarcinoma; Brain Neoplasms; Breast Neoplasms; Cell Survival; Cholesterol; Cobalt Radioisotopes; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cyclohexenes; Dose-Response Relationship, Radiation; Female; Fibrosarcoma; Gamma Rays; Genes, ras; Glioblastoma; Humans; Limonene; Lung Neoplasms; Male; Mevalonic Acid; Prostatic Neoplasms; Radiation-Sensitizing Agents; Terpenes; Tumor Cells, Cultured | 1997 |